Client Overview/Background: iNova has leading consumer healthcare and specialty prescription brands in over 15 countries, including Australia, New Zealand, Asia Pacific and Africa regions. Formerly 3M Pharmaceuticals, the manufacturing activities had been located at the Thornleigh site for over 40 years.
The Brief: PCG’s brief was to play a role in assisting the restructure of the organisation through the divestiture of property, acquisition of new leasehold property and the creation of a new workplace which would enable the business and its employees to operate more effectively and productively.
In addition to the above, during the course of the project, iNova was acquired by Valeant, a Canadian based public company in the pharmaceutical sector. This acquisition brought a new dynamic to the project and involved the integration of two organisational cultures. This was achieved through a comprehensive change management and branding strategy.
The Strategy/Solution: This project called upon PCG’s corporate real estate, project management and interior architecture services to deliver against the clients requirements.
The first challenge involved our CRE professionals achieving a timely divestiture of the freehold manufacturing site comprising approximately 2.98 hectares with improvements comprising extensive process, warehousing, and office accommodation. PCG called proposals from agents, managed the marketing campaign and conducted the negotiations with the purchaser.
The second challenge involved the property and project personnel envisioning the new leasehold workplace with the key client stakeholders then briefing the market, negotiating lease terms and undertaking the design and project management of a new high performance workplace for in excess of 140 pharmaceutical professionals in Chatswood.
Both projects were conducted concurrently by a dedicated project team which were afforded early involvement with key iNova stakeholders which was critical to project success.
"The compelling proposition PCG offered was their independence and end-to-end capacity, whilst we are experts in pharmaceutical manufacturing and marketing we know little about property, design, and project management. Whilst we were confident in the ability of the other parties to do their jobs, they were heavily reliant on others to deliver the full complement of the required deliverables.
We imposed a number of very tight time lines on PCG and despite the unfortunate market conditions and some occurrences outside their control, PCG delivered everything we wanted on time and the staff and management are exceedingly happy."
Chief Executive Officer